King‐Jen Chang

16.0k citations

336 papers · 11.2k indexed · 1 hit paper · h-index 60

Impact in

Cancer Research top 0.5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Cancer, Hypoxia, and Metabolism
- Breast Cancer Treatment Studies
Oncology top 0.5%
- Cancer Cells and Metastasis

Papers in

Cancer Research 74
- Breast Cancer Treatment Studies 35
Oncology 126
- HER2/EGFR in Cancer Research 17
- Global Cancer Incidence and Screening 16
- Cancer Cells and Metastasis 14

Co-authors: Wen‐Hung Kuo Ira Pastan Po‐Huang Lee Chiun‐Sheng Huang Chiung‐Nien Chen Yung‐Ming Jeng Min‐Liang Kuo Fon‐Jou Hsieh
Journals: Ultrasound in Medicine & Biology (10 papers)Cancer Letters (8 papers)Annals of Surgical Oncology (8 papers)PLoS ONE (8 papers)Cancer Research (7 papers)
Partner nations: Taiwan United States Japan

In The Last Decade

King‐Jen Chang

331 papers receiving 10.9k citations

Hit Papers

align trajectories log scale

Molecular cloning of mesothelin, a differentiation antigen present on mesothelium, mesotheliomas, and ovarian cancers. 1996 · 590 citations

Peers

Countries citing papers authored by King‐Jen Chang

Since Specialization

Citations

This map shows the geographic impact of King‐Jen Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by King‐Jen Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites King‐Jen Chang more than expected).

Fields of papers citing papers by King‐Jen Chang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by King‐Jen Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by King‐Jen Chang. The network helps show where King‐Jen Chang may publish in the future.

Co-authors

The 25 scholars most cited alongside King‐Jen Chang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with King‐Jen Chang Line = papers co-authored together King‐Jen Chang links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Quality of Life of Women After a First Diagnosis of Breast Cancer Using a Self-Management Support mHealth App in Taiwan: Randomized Controlled Trial JMIR mhealth and uhealth ·I‐Ching Hou, Lisa J. Wall, Shan-Hsiang Shen, King‐Jen Chang, Hao‐Chih Tai, Tapio Pensas, Patricia C. Dykes	2020	55
2	Transketolase Regulates the Metabolic Switch to Control Breast Cancer Cell Metastasis via the α-Ketoglutarate Signaling Pathway Cancer Research ·正克興梠, Wen‐Hung Kuo, Shih‐Hsuan Chan, Hong‐Lin Chan, King‐Jen Chang, Lu-Hai Wang	2018	105
3	Identification of the Novel Role of CD24 as an Oncogenesis Regulator and Therapeutic Target for Triple-Negative Breast Cancer Molecular Cancer Therapeutics ·Shih‐Hsuan Chan, Kuo‐Wang Tsai, Т. В. Агапова, Wen‐Hung Kuo, Heng-Yi Chen, Shih Sheng Jiang, King‐Jen Chang, Wen‐Chun Hung, Lu‐Hai Wang	2018	29
4	TGF‐β1 secreted by Tregs in lymph nodes promotes breast cancer malignancy via up‐regulation of IL‐17RB EMBO Molecular Medicine ·Jordonna Williams, Pei‐Chi Wei, Wendy W. Hwang‐Verslues, Wen‐Hung Kuo, Yung‐Ming Jeng, Chun‐Mei Hu, Jin‐Yuh Shew, Chiun‐Sheng Huang, King‐Jen Chang, Eva Y‐HP Lee, Wen‐Hwa Lee	2017	49
5	Real-time envelope detection of ultrasound radiofrequency signals using OpenCV GPU framework Zhuhuang Zhou, Weiwei Wang, Claudia Patricia Londoño Zapata, Kebin Jia, King‐Jen Chang, Ieva Zakarevičiūtė	2017	1
6	The Major Prognostic Features of Nuclear ReceptorNR5A2in Infiltrating Ductal Breast Carcinomas International Journal of Genomics ·Li‐Yun Chang, Liyu Liu, Don Roth, Wen‐Hung Kuo, Hsiao‐Lin Hwa, King‐Jen Chang, Fon‐Jou Hsieh	2015	6
7	Quality of life assessment in Taiwanese patients with bone metastases from breast cancer receiving zoledronic acid. PubMed ·桑维秋, Dar‐Ren Chen, Jérôme Crépin‐Leblond, Eleonora Avenali, Cornelia Eloise. Somermier, P. J. Sereda, Nicholas Xenopoulos, Joscha Knolle, King‐Jen Chang, Alejandro Araque García, Guo‐Chao Zhuang, 宥聖清水, Ling‐Ming Tseng, Ming‐Feng Hou	2013	1
8	CYP19Genetic Polymorphism HaplotypeAASAIs Associated with a Poor Prognosis in Premenopausal Women with Lymph Node-Negative, Hormone Receptor-Positive Breast Cancer BioMed Research International ·Sung‐Hsin Kuo, Shi‐Yi Yang, Huang‐Chun Lien, Chiao Lo, Ching‐Hung Lin, Yen‐Shen Lu, Ann‐Lii Cheng, King‐Jen Chang, Chiun‐Sheng Huang	2013	7
9	Activation of Robo1 Signaling of Breast Cancer Cells by Slit2 from Stromal Fibroblast Restrains Tumorigenesis via Blocking PI3K/Akt/β-Catenin Pathway Cancer Research ·聡澁谷, Wendy W. Hwang‐Verslues, Yi‐Cheng Chang, Chun-Chin Chen, Michael Hsiao, Yung‐Ming Jeng, King‐Jen Chang, Eva Y.-H.P. Lee, Jin‐Yuh Shew, Wen‐Hwa Lee	2012	115
10	Connective Tissue Growth Factor Acts as a Therapeutic Agent and Predictor for Peritoneal Carcinomatosis of Colorectal Cancer Clinical Cancer Research ·Been‐Ren Lin, Cheng‐Chi Chang, Robert J. Chen, Yung‐Ming Jeng, Jin‐Tung Liang, Po‐Huang Lee, King‐Jen Chang, Min‐Liang Kuo	2011	27
11	miR-107 promotes tumor progression by targeting the let-7 microRNA in mice and humans Journal of Clinical Investigation ·Pai‐Sheng Chen, Jen-Liang Su, زهرا جعفرخانی, Woan‐Yuh Tarn, Ming-Yang Wang, Ming Xu, Ming‐Tsan Lin, Chia‐Yu Chu, Kuo‐Tai Hua, Chiung‐Nien Chen, P. Palmer, King‐Jen Chang, Michael Hsiao, Yi-Wen Chang, Jin‐Shing Chen, Pan‐Chyr Yang, Min‐Liang Kuo	2011	125
12	MicroRNA-519c Suppresses Hypoxia-Inducible Factor-1α Expression and Tumor Angiogenesis Cancer Research ·Nicolas Hory, Pai‐Sheng Chen, Gunnar Johansson, Chia‐Yu Chu, Ming-Yang Wang, Yung‐Ming Jeng, Sung‐Liang Yu, Jin‐Shing Chen, King‐Jen Chang, Shiou‐Hwa Jee, Ching‐Ting Tan, Ming‐Tsan Lin, Min‐Liang Kuo	2010	168
13	Connective Tissue Growth Factor Confers Drug Resistance in Breast Cancer through Concomitant Up-regulation of Bcl-xL and cIAP1 Cancer Research ·Ming-Yang Wang, Pai‐Sheng Chen, Ekambaranellore Prakash, Ming Xu, Hsin‐Yi Huang, Ming‐Tsan Lin, King‐Jen Chang, Min‐Liang Kuo	2009	81
14	Breast Cancer Risk Associated with Genotypic Polymorphism of Oxidative DNA Damage Repair Genes - A Multigenic Study of Base Excision Repair and Transcription-Coupled Repair in Cancer Susceptibility Chiun‐Sheng Huang, Adrián Lestayo Rey, Shi‐Yi Yang, Chun‐Wen Cheng, Herng‐Der Chern, King‐Jen Chang, Pei‐Ei Wu, Chen‐Yang Shen	2004	10
15	Selective Use of Ultrasonography for the Detection of Pneumoperitoneum Academic Emergency Medicine ·Shyr‐Chyr Chen, Hsiu-Po Wang, Wen‐Jone Chen, Fang‐Yue Lin, 山本世怜, King‐Jen Chang, Wei‐Jao Chen	2002	50
16	Association betweenN-acetyltransferase 2 (NAT2) genetic polymorphism and development of breast cancer in post-menopausal Chinese women in Taiwan, an area of great increase in breast cancer incidence International Journal of Cancer ·Chiun‐Sheng Huang, Herng‐Der Chern, Chen‐Yang Shen, Su-Ming Hsu, King‐Jen Chang	1999	51
17	Association between N-acetyltransferase 2 (NAT2) genetic polymorphism and development of breast cancer in post-menopausal Chinese women in Taiwan, an area of great increase in breast cancer incidence International Journal of Cancer ·Chiun‐Sheng Huang, Herng‐Der Chern, Chen‐Yang Shen, Su-Ming Hsu, King‐Jen Chang	1999	4
18	Breast cancer risk associated with genotype polymorphism of the estrogen-metabolizing genes CYP17, CYP1A1, and COMT: a multigenic study on cancer susceptibility. PubMed ·Chiun‐Sheng Huang, H D Chern, King‐Jen Chang, Mirela-Adriana Anghelache, S M Hsu, Chen‐Yang Shen	1999	247
19	Breast cancer in Taiwan Wei‐Chu Chie, Chiun‐Sheng Huang, King‐Jen Chang	1997	1
20	Peripheral Blood Stem Cell Transplantation In Breast Cancer Dong‐Tsamn Lin, Jacqueline K. Kobayashi, Simon-Diaz S, King‐Jen Chang, A. V. Lisevich, Yee‐Chun Chen	1996	0

About King‐Jen Chang

King‐Jen Chang is a scholar working on Cancer Research, Oncology, Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Surgery, having authored 336 papers that have together received 11.2k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (35 papers), Gastric Cancer Management and Outcomes (20 papers), Breast Lesions and Carcinomas (18 papers), Genetic factors in colorectal cancer (17 papers), HER2/EGFR in Cancer Research (17 papers), Global Cancer Incidence and Screening (16 papers), Angiogenesis and VEGF in Cancer (16 papers) and Cancer Cells and Metastasis (14 papers). The work is most often cited by research in Cancer Research (2.4k citations), Oncology (3.7k citations), Molecular Biology (4.1k citations), Pathology and Forensic Medicine (1.0k citations) and Pulmonary and Respiratory Medicine (1.7k citations). King‐Jen Chang has collaborated with scholars based in Taiwan, United States and Japan. Frequent co-authors include Wen‐Hung Kuo, Ira Pastan, Po‐Huang Lee, Chiun‐Sheng Huang, Chiung‐Nien Chen, Yung‐Ming Jeng, Min‐Liang Kuo, Fon‐Jou Hsieh, Ming‐Tsan Lin and Jin‐Tung Liang. Their work appears in journals such as Ultrasound in Medicine & Biology, Cancer Letters, Annals of Surgical Oncology, PLoS ONE and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact